GILD vs VCTR · P/E 18, rev $29.44B vs P/E 14, rev $893.5M
Gilead Sciences Inc (GILD) versus Victory Capital Holdings Inc (VCTR) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Victory Capital Holdings Inc (VCTR) is a asset management company listed on US.
Latest reported GILD revenue for 2025-12-31 was $29.44B. Net income was $8.51B. Revenue was up 2.4% from 2024-12-31 to 2025-12-31. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported VCTR revenue for 2024-12-31 was $893.5M. Net income was $288.9M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. VCTR currently screens at market cap $4.35B and trailing P/E 14.4.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. VCTR currently screens at market cap $4.35B and trailing P/E 14.4.
Not investment advice. Open the GILD and VCTR stock pages for the full models.
Not investment advice.